CN117860958B - Octopus-based ink-jet type temperature-sensitive antibacterial dressing, and preparation method and application thereof - Google Patents
Octopus-based ink-jet type temperature-sensitive antibacterial dressing, and preparation method and application thereof Download PDFInfo
- Publication number
- CN117860958B CN117860958B CN202410039388.XA CN202410039388A CN117860958B CN 117860958 B CN117860958 B CN 117860958B CN 202410039388 A CN202410039388 A CN 202410039388A CN 117860958 B CN117860958 B CN 117860958B
- Authority
- CN
- China
- Prior art keywords
- gelatin
- dressing
- poloxamer
- shell
- hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 43
- 241000238413 Octopus Species 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 108010010803 Gelatin Proteins 0.000 claims abstract description 49
- 239000008273 gelatin Substances 0.000 claims abstract description 49
- 229920000159 gelatin Polymers 0.000 claims abstract description 49
- 235000019322 gelatine Nutrition 0.000 claims abstract description 49
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 49
- 230000029663 wound healing Effects 0.000 claims abstract description 16
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 71
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 67
- 229920001992 poloxamer 407 Polymers 0.000 claims description 61
- 229940044476 poloxamer 407 Drugs 0.000 claims description 61
- 239000000017 hydrogel Substances 0.000 claims description 46
- 239000011787 zinc oxide Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 16
- 239000000725 suspension Substances 0.000 claims description 16
- 239000002131 composite material Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 238000010146 3D printing Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 238000007639 printing Methods 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 29
- 206010052428 Wound Diseases 0.000 abstract description 28
- 239000000463 material Substances 0.000 abstract description 7
- 230000028709 inflammatory response Effects 0.000 abstract description 4
- 238000013270 controlled release Methods 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 238000004626 scanning electron microscopy Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000004627 transmission electron microscopy Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010048038 Wound infection Diseases 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 3
- 108010087230 Sincalide Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 1
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000001248 thermal gelation Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002723 toxicity assay Methods 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0038—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses an octopus-based ink-jet type temperature-sensitive antibacterial dressing, and a preparation method and application thereof, wherein the dressing comprises a shell and an antibacterial component filled in an inner cavity of the shell; the outer shell is of a box-shaped structure, the surface of the outer shell is provided with a plurality of nozzles, and the antibacterial components in the outer shell are released to the affected part through the nozzles. The dressing of the invention not only solves the problem that the wound dressing at the sport position is easy to fall off and deform, so that the wound dressing can be individually deformed according to the sport and keep the integrity of the material, but also realizes the intelligent controlled release of antibacterial components with inflammatory response through the temperature sensitivity of gelatin so as to promote wound healing, thereby providing a possible new scheme for solving the clinical problems. Meanwhile, the preparation method disclosed by the invention is simple and convenient to operate, low in cost and high in practicability, so that the dressing obtained by the preparation method has a good application prospect in wound healing of a sport part.
Description
Technical Field
The invention relates to the technical field of biomedical materials, in particular to an octopus-based ink-jet type temperature-sensitive antibacterial dressing, and a preparation method and application thereof.
Background
Skin is considered to be the most important barrier of the human body against invasion by physical, mechanical, chemical and pathogenic microorganisms, and when the integrity of the skin is compromised, bleeding, infection, pain, dysfunction, and even life threatening may result. Wound healing is a dynamic continuous process that includes hemostasis, inflammatory response, cell proliferation, angiogenesis and tissue regeneration, with corresponding changes in the wound microenvironment at different stages. The healing time of the wound is generally different in 3-14 days, the healing time of different parts is different, and the healing time of the wound of the jaw face is generally faster, and the wound of the part can be better recovered in 3-5 days because the blood supply of the jaw face is rich; the wound on the abdomen needs 5-7 days to heal, the wound on the chest and back needs 7-10 days, the wound on the limbs needs about 10-12 days, and the wound on the exercise parts such as joints is relatively longer in about 14 days. Wound healing is a natural and stable process under normal conditions, but when the organism immunity is low, the wound is exposed seriously, or the wounded suffers from systemic diseases such as diabetes mellitus, the invasion of pathogenic microorganisms easily occurs to cause wound infection, and the wound healing is hindered. To avoid this list of complications, we should perform bandaging interventions immediately after injury for vulnerable wounds.
In recent years, researches on wound healing dressings have been endless, such as wound dressings for diabetics, wound dressings with wet adhesion performance and the like, however, researches on wound healing dressings for maxillofacial and other sports parts have been relatively few, and although the wound blood supply of maxillofacial is short in healing time, maxillofacial wound healing is often affected by movements such as maxillofacial expression, chewing and the like, and in addition, wound healing at sports wounds such as joints at other parts of the body is greatly affected by movements. The wound at the exercise position is not only healed for a long time, but also the dressing is difficult to be completely attached to the wound due to exercise, so that the probability of wound infection is greatly increased. Therefore, the wound healing of the sports parts such as the maxillofacial part still has great challenges, so that a novel bionic sports wound dressing needs to be built, has enough ductility and toughness, and can realize complete fit and continuous antibacterial effect on the sports part wound, thereby promoting the healing of the sports part wound.
In view of this, the present invention has been made.
Disclosure of Invention
The invention aims to provide an octopus-based ink-jet type temperature-sensitive antibacterial dressing, a preparation method and application thereof.
The invention is realized in the following way:
in a first aspect, the invention provides an octopus-based ink-jet type temperature-sensitive antibacterial dressing, which comprises a shell and an inner antibacterial component filled in the inner cavity of the shell; the outer shell is of a box-shaped structure, the surface of the outer shell is provided with a plurality of nozzles, and the antibacterial components in the outer shell are released to the affected part through the nozzles.
In a second aspect, the invention also provides a preparation method of the octopus-based inkjet-type temperature-sensitive antibacterial dressing, which comprises the following steps: and printing the poloxamer 407 hydrogel solution out of a groove structure of the shell through a 3D printing technology, extruding mixed suspension of gelatin/zinc oxide composite hydrogel into the groove structure, and sealing the groove structure by using the poloxamer 407 hydrogel solution to form a box-shaped structure, wherein the sealed surface contains a plurality of nozzle structures.
In a third aspect, the invention also provides application of the octopus-based ink-jet type temperature-sensitive antibacterial dressing in preparation of medicines for promoting wound healing at a sport site.
The invention has the following beneficial effects:
The invention designs a novel composite dressing through a bionic structure of octopus ink-jet, the outer shell of the dressing is of a box-shaped structure, a plurality of nozzles are arranged on the surface of the box-shaped structure, and antibacterial components in the dressing are released through the nozzles. The dressing not only solves the problem that the wound dressing at the exercise is easy to fall off and deform, so that the wound dressing can be subjected to personalized deformation according to the exercise while keeping the integrity of the material, but also realizes the intelligent controlled release of antibacterial components with inflammatory response through the temperature sensitivity of gelatin so as to promote wound healing, and provides a possible new scheme for solving the clinical problem. Meanwhile, the preparation method disclosed by the invention is simple and convenient to operate, low in cost and high in practicability, so that the dressing obtained by the preparation method has a good application prospect in wound healing of a sport part.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are needed in the embodiments will be briefly described below, it being understood that the following drawings only illustrate some embodiments of the present invention and therefore should not be considered as limiting the scope, and other related drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
Fig. 1 is a structural view of an octopus-based ink-jet type temperature-sensitive antibacterial dressing according to the present invention, wherein the upper view is an overall structure, and the lower view is a side view;
FIG. 2 is a graph showing the contact angle measurements of the outer ink sac and inner ink structure of the dressing of example 1;
FIG. 3 is a scanning electron microscope block diagram of the dressing of example 1;
FIG. 4 shows the comparison of cell proliferation activities of different experimental groups in experimental example 2;
FIG. 5 shows the results of cell adhesion experiments for different experimental groups in Experimental example 2;
FIG. 6 shows the results of bacterial plate coating for different experimental groups in Experimental example 3;
FIG. 7 is a scanning electron microscope image of E.coli and Staphylococcus aureus of different experimental groups in experimental example 3;
FIG. 8 is a transmission electron micrograph of E.coli and Staphylococcus aureus of different experimental groups in Experimental example 3.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention more clear, the technical solutions of the embodiments of the present invention will be clearly and completely described below. The specific conditions are not noted in the examples and are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
The inventor designs a temperature sensitive wound dressing which releases antibacterial components along with movement according to the principle of ink jet of an octopus ink sac, and the structure of the dressing is as follows:
the outer shell is in a box-shaped structure, the upper surface is provided with a plurality of nozzles; the antibacterial component of the inner cavity is in a gel state at normal temperature, and is filled in the inner cavity of the box-shaped structure. Wherein, the components of the shell comprise poloxamer 407 hydrogel, and the antibacterial components of the inner cavity comprise gelatin/zinc oxide composite hydrogel. The specific structure of the dressing is shown in fig. 1.
The dressing bionic octopus ink bag ink jet is designed with the structure, so that the dressing can not only meet the close fit of wound dressing at a sport position and not fall off along with continuous movement, but also continuously release ZnO along with movement to prevent wound infection, thereby promoting wound healing.
Specifically, poloxamer 407 (PO) corresponds to the ink sac structure of the octopus, gelatin/ZnO (GZ) mimics the ink structure in the octopus ink sac, and releases the relevant antibacterial factors along with the expansion and contraction of the outer ink sac structure during exercise.
In order to obtain better performance of the dressing, the inventor of the invention also optimizes the concentration of poloxamer 407, the concentration of gelatin and the concentration ratio of gelatin to zinc oxide so as to obtain better mechanical strength and toughness.
In the invention, the mass ratio of poloxamer 407 to water is 1:3-20, the mass ratio of gelatin to water is 1:5-20, and the mass ratio of gelatin to ZnO is 400-1000:1.
The poloxamer 407 is selected as the raw material of the shell, because the poloxamer 407 is a polyethylene glycol-polypropylene glycol-polyethylene glycol triblock copolymer, the invention has good thermal gelation property and excellent biocompatibility; the zinc oxide is selected as the antibacterial substance in the inner cavity because the ZnO nanomaterial can release Zn 2+, while Zn 2+ can react with-SH groups on proteins to destroy enzymes of an electron transfer system on a bacterial cell membrane. Meanwhile, znO is easier to generate active oxygen than other oxidized nano materials, so that ZnO has better antibacterial effects on staphylococcus aureus, escherichia coli and the like; gelatin is selected as a carrier because gelatin is a macromolecular hydrophilic collagen hydrolysate, is heated and dissolved into colloid, becomes gel-like when cooled to below 35-40 ℃, can become liquid when a wound is in inflammation heating condition, quickly releases ZnO, reduces skin surface temperature when inflammation does not occur or the inflammation subsides, deteriorates gelatin fluidity, and releases ZnO relatively slowly. From the results, poloxamer 407/gelatin/ZnO (PO/GZ) wound dressing realizes inflammatory response controlled release and slow release ZnO according to the temperature-sensitive change of gelatin.
The preparation method of the dressing with the structure comprises the following steps:
S1, adding poloxamer 407 powder into water, and uniformly stirring at the temperature of 2-4 ℃ to prepare poloxamer 407 hydrogel solution. Wherein the mass ratio of poloxamer 407 to water is 1:3-20.
S2, adding the gelatin powder into water, and uniformly stirring at 50-60 ℃ to prepare semitransparent uniform gelatin hydrogel solution. Wherein the mass ratio of the gelatin to the water is 1:5-20.
S3, adding ZnO powder into the gelatin hydrogel solution, and uniformly stirring at 50-60 ℃ to prepare suspension. Wherein the mass ratio of gelatin to ZnO is 400-1000:1.
S4, printing the poloxamer 407 hydrogel solution out of a groove structure of the shell through a 3D printing technology, extruding mixed suspension of gelatin/zinc oxide composite hydrogel into the groove structure, and sealing the groove structure through the poloxamer 407 hydrogel solution to form a box-shaped structure, wherein the surface of the seal is provided with a plurality of nozzle structures.
S5, obtaining the antibacterial temperature-sensitive dressing-PO/GZ.
The features and capabilities of the present invention are described in further detail below in connection with the examples.
Example 1
The embodiment provides an octopus-based ink-jet type temperature-sensitive antibacterial dressing, and the structure of the dressing is shown in fig. 1: the shell is poloxamer 407 hydrogel, the inner cavity is gelatin/zinc oxide composite hydrogel, and the specific preparation method is as follows:
(1) Adding poloxamer 407 powder into pure water according to the mass ratio of 1:3, and uniformly stirring at 2-4 ℃ to completely dissolve the poloxamer 407 powder into the pure water to form poloxamer 407 hydrogel solution;
(2) Adding gelatin powder into pure water according to the mass ratio of 1:5, heating to 50-60 ℃, and uniformly stirring to form semitransparent uniform gelatin hydrogel solution;
(3) Then adding ZnO powder into gelatin hydrogel solution according to the mass ratio of gelatin to ZnO of 400:1, heating to 50-60 ℃, and stirring to form uniform suspension;
(4) And printing the poloxamer 407 hydrogel solution out of a groove structure of the shell through a 3D printing technology, extruding mixed suspension of gelatin/zinc oxide composite hydrogel into the groove structure, and sealing the groove structure by using the poloxamer 407 hydrogel solution to form a box-shaped structure, wherein the sealed surface contains a plurality of nozzle structures.
(5) Finally, the antibacterial temperature-sensitive dressing-PO/GZ is obtained.
Example 2
The embodiment provides an octopus-based ink-jet type temperature-sensitive antibacterial dressing, wherein the shell of the dressing is poloxamer 407 hydrogel, the inner cavity is gelatin/zinc oxide composite hydrogel, and the specific preparation method comprises the following steps:
(1) Adding poloxamer 407 powder into pure water according to the mass ratio of 1:10, and uniformly stirring at 2-4 ℃ to completely dissolve the poloxamer 407 powder into the pure water to form poloxamer 407 hydrogel solution;
(2) Adding gelatin powder into pure water according to the mass ratio of 1:10, heating to 50-60 ℃, and uniformly stirring to form semitransparent and uniform gelatin hydrogel solution;
(3) Then adding ZnO powder into gelatin hydrogel solution according to the mass ratio of gelatin to ZnO of 800:1, heating to 50-60 ℃, and stirring to form uniform suspension;
(4) And printing the poloxamer 407 hydrogel solution out of a groove structure of the shell through a 3D printing technology, extruding mixed suspension of gelatin/zinc oxide composite hydrogel into the groove structure, and sealing the groove structure by using the poloxamer 407 hydrogel solution to form a box-shaped structure, wherein the sealed surface contains a plurality of nozzle structures.
(5) Finally, the antibacterial temperature-sensitive dressing-PO/GZ is obtained.
Example 3
The embodiment provides an octopus-based ink-jet type temperature-sensitive antibacterial dressing, wherein the shell of the dressing is poloxamer 407 hydrogel, the inner cavity is gelatin/zinc oxide composite hydrogel, and the specific preparation method comprises the following steps:
(1) Adding poloxamer 407 powder into pure water according to the mass ratio of 1:20, and uniformly stirring at 2-4 ℃ to completely dissolve the poloxamer 407 powder into the pure water to form poloxamer 407 hydrogel solution;
(2) Adding gelatin powder into pure water according to the mass ratio of 1:20, heating to 50-60 ℃, and uniformly stirring to form semitransparent uniform gelatin hydrogel solution;
(3) Then adding ZnO powder into gelatin hydrogel solution according to the mass ratio of gelatin to ZnO of 1000:1, heating to 50-60 ℃, and stirring to form uniform suspension;
(4) And printing the poloxamer 407 hydrogel solution out of a groove structure of the shell through a 3D printing technology, extruding mixed suspension of gelatin/zinc oxide composite hydrogel into the groove structure, and sealing the groove structure by using the poloxamer 407 hydrogel solution to form a box-shaped structure, wherein the sealed surface contains a plurality of nozzle structures.
(5) Finally, the antibacterial temperature-sensitive dressing-PO/GZ is obtained.
Comparative example 1
The difference from example 1 is that the dressing was a dressing structure without gelatin/zinc oxide inner shell, namely poloxamer 407 (PO) dressing, and the comparative test results of comparative example 1 and experimental example 1 are as follows.
Experimental example 1
The dressing obtained in example 1 was subjected to contact angle detection by the following method: the relatively flat surfaces of PO and PO/GA were used as test surfaces, and the contact angle was calculated by measuring the angle between the contact line of the droplet (water) on the PO and PO/GA surfaces and the horizontal line. The number of PO and PO/GA groups was 6 in parallel.
The detection results are shown in fig. 2: the outer PO contact angle range was 19.179 ° and the inner GA contact angle range was 9.087 °.
The detection results prove that the dressing provided by the invention has good hydrophilicity, can release gelatin/ZnO (GZ) along with movement, can absorb inflammatory exudation at a wound, and can promote wound healing.
Meanwhile, the dressing obtained in the embodiment is observed through a scanning electron microscope, and the result is shown in fig. 3: the figure shows that the antibacterial auxiliary material has a good porous loose structure, and is beneficial to release and absorption of liquid.
Experimental example 2
The experimental example is a biological safety evaluation on the dressing in the example, and the evaluation method is as follows: first, cell proliferation-toxicity assays were performed for 1,3,5 days using the CCK-8 kit. Cells were seeded into 96-well plates and after 24 hours of incubation, media containing different sets of material was added to the plates. After 1d, 3d, 5d incubation, a pre-prepared CCK-8 solution was added to each well, incubated at 37 ℃ and absorbance measurements were performed using a microplate reader at a wavelength of 450nm, taking care to keep out light throughout the procedure. Then, in this experimental example, scanning electron microscope observation of cell adhesion was performed to further evaluate the biocompatibility, cells were inoculated onto the surface of the material, incubated for 4 hours, 1 day, and short-term and long-term adhesion morphology of the cells was observed by SEM. Cell samples were collected at different time points, cells were fixed using glutaraldehyde, and samples were dehydrated using gradient ethanol, and finally dried in a vacuum desiccator for SEM observation.
The experimental results are shown in fig. 4-5, and compared with the control CCK8 detection results, poloxamer 407 (PO) and poloxamer 407/gelatin/ZnO (PO/GZ) groups have no significant toxicity, and cells show good proliferation activity with increasing days. 4 hours and 1 day of cell adhesion experiments show that all 3 groups of cells have good adhesion and stretching morphology, and further prove that PO/GZ has good biocompatibility.
Experimental example 3
The experimental example is to verify the antibacterial performance of the dressing in the embodiment, and the verification method is as follows: coli (e.coil) and staphylococcus aureus (s.aureus) were used as subjects to examine the antibacterial ability of this example.
Firstly, an agar plate coating method is adopted to detect the antibacterial capability, PO or PO/GZ is used for treating bacterial suspension for 24 hours, and after dilution is carried out for a certain multiple, a coater is used for coating the dilution on an LB agar plate. The culture was performed at 37℃for 24 hours, and then the image was collected. Morphological changes of bacteria were observed using Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM), sample preparation of SEM: and adding PO or PO/GZ into the bacterial suspension, incubating for 12 hours at 37 ℃, centrifugally collecting bacteria, fixing a sample by glutaraldehyde solution, sequentially dehydrating by gradient ethanol, drying the sample, spraying gold, and finally recording images by using a scanning electron microscope. Sample preparation of TEM: PO or PO/GZ is added to the bacterial suspension. After incubation for 12h at 37 ℃, bacteria are collected by centrifugation, glutaraldehyde and paraformaldehyde solution are added for fixation, then supernatant is removed by centrifugation, bacterial precipitate is collected at the bottom of a tube, soybean size is washed by PBS, supernatant is removed by centrifugation, new fixative is slowly added along the tube wall, then the tube is placed in a refrigerator at 4 ℃ for overnight, and finally TEM observation is carried out.
As shown in FIG. 6, the bacterial plate coating experiments showed that the PO/GZ group had good antibacterial effect against E.coli (E.coil) and Staphylococcus aureus (S.aureus), whereas the PO group did not have significant antibacterial effect compared to the control group.
As shown in fig. 7 and 8, the results of Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM) also confirmed the conclusion that the e.coil and s.aureus of the PO group did not have significant shape and size changes compared to the control group. In contrast, the PO/GZ groups E.coil and S.aureus show shrinkage, wrinkles and partial cracks. Therefore, the PO/GZ antibacterial auxiliary material can be proved to have good antibacterial performance by the figures 6-8.
The above description is only of the preferred embodiments of the present invention and is not intended to limit the present invention, but various modifications and variations can be made to the present invention by those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (9)
1. An octopus-based ink-jet type temperature-sensitive antibacterial dressing is characterized by comprising a shell and an antibacterial component filled in the inner cavity of the shell; the shell is of a box-shaped structure, the surface of the shell is provided with a plurality of nozzles, and the internal antibacterial components are released to an affected part through the nozzles;
the components of the shell comprise poloxamer 407 hydrogel, and the components of the inner cavity comprise gelatin/zinc oxide composite hydrogel.
2. The dressing of claim 1, wherein the contact angle of the poloxamer 407 hydrogel is 10-20 ° and the contact angle of the gelatin/zinc oxide composite hydrogel is 6-15 °.
3. A method of preparing an octopus inkjet-based temperature-sensitive antibacterial dressing according to claim 1 or 2, comprising: and printing the poloxamer 407 hydrogel solution out of a groove structure of the shell through a 3D printing technology, extruding a mixed suspension of gelatin/zinc oxide composite hydrogel into the groove structure, and sealing the groove structure by using the poloxamer 407 hydrogel solution to form a box-shaped structure, wherein the sealed surface contains a plurality of nozzle structures.
4. The method of preparing the poloxamer 407 hydrogel solution according to claim 3, comprising: adding poloxamer 407 powder into water, and uniformly stirring to prepare poloxamer 407 hydrogel solution; the temperature of the stirring is 2-4 ℃.
5. The preparation method according to claim 4, wherein the mass ratio of poloxamer 407 to water is 1:3-20.
6. The method of preparing the mixed suspension according to claim 5, wherein the method of preparing the mixed suspension comprises: adding the gelatin solution into water, and stirring uniformly at high temperature to prepare gelatin hydrogel solution; adding zinc oxide powder into gelatin hydrogel solution, stirring at high temperature to obtain suspension; the stirring temperature at the high temperature is 50-60 ℃.
7. The method of claim 6, wherein the mass ratio of gelatin to water is 1:5-20.
8. The method according to claim 7, wherein the mass ratio of gelatin to zinc oxide is 400-1000:1.
9. Use of an octopus inkjet-based temperature-sensitive antibacterial dressing according to claim 1 or 2 for the preparation of a medicament for promoting wound healing at a sport site.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410039388.XA CN117860958B (en) | 2024-01-10 | 2024-01-10 | Octopus-based ink-jet type temperature-sensitive antibacterial dressing, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410039388.XA CN117860958B (en) | 2024-01-10 | 2024-01-10 | Octopus-based ink-jet type temperature-sensitive antibacterial dressing, and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117860958A CN117860958A (en) | 2024-04-12 |
CN117860958B true CN117860958B (en) | 2024-09-03 |
Family
ID=90587925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410039388.XA Active CN117860958B (en) | 2024-01-10 | 2024-01-10 | Octopus-based ink-jet type temperature-sensitive antibacterial dressing, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117860958B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3063832A1 (en) * | 2017-05-17 | 2018-11-22 | Uvic Industry Partnerships Inc. | Wound covering for wound monitoring and therapeutic agent delivery |
AU2019203167A1 (en) * | 2010-11-10 | 2019-05-30 | Prokidney | Injectable formulations for organ augmentation |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008036225A2 (en) * | 2006-09-20 | 2008-03-27 | Entek Manufacturing, Inc. | Conformable structured therapeutic dressing |
WO2008130641A1 (en) * | 2007-04-20 | 2008-10-30 | Biocure, Inc. | Drug delivery vehicle containing vesicles in a hydrogel base |
CN105597146B (en) * | 2016-01-20 | 2018-08-07 | 中山大学 | Wound healing multi-functional temperature sensitive gel composite dressing and its preparation and application method |
CN109731130B (en) * | 2018-11-14 | 2021-09-24 | 华中科技大学同济医学院附属协和医院 | Method for preparing hydrogel wound dressing by low-temperature biological 3D printing technology |
CN111375091B (en) * | 2018-12-30 | 2021-09-10 | 中国科学院沈阳自动化研究所 | Photosensitive composite biological ink for 3D printing and preparation method thereof |
CN111437431A (en) * | 2020-03-26 | 2020-07-24 | 吉林大学 | Exosome hydrogel wound dressing and preparation method thereof |
CN111686295A (en) * | 2020-06-24 | 2020-09-22 | 重庆理工大学 | Seepage self-adjusting composite dressing and preparation method thereof |
KR102431839B1 (en) * | 2020-08-10 | 2022-08-12 | 한국과학기술연구원 | Composition for wound treatment or tissue regeneration comprising a mixture of poloxamer, hyaluronic acid, and extracellular matrix and use thereof |
CN112354003A (en) * | 2020-10-20 | 2021-02-12 | 汕头大学 | Composite hydrogel dressing and preparation method thereof |
CN114989462A (en) * | 2022-07-08 | 2022-09-02 | 大连大学 | Temperature-sensitive hydrogel material and preparation method thereof |
CN115721767B (en) * | 2022-12-12 | 2024-03-12 | 广东省人民医院 | Antibacterial healing-promoting porous medical dressing and preparation method thereof |
CN116440316A (en) * | 2023-03-30 | 2023-07-18 | 华南理工大学 | Antibacterial hydrogel with dual temperature response function and preparation method and application thereof |
CN116763979A (en) * | 2023-07-13 | 2023-09-19 | 复旦大学 | Dressing capable of promoting chronic wound healing |
-
2024
- 2024-01-10 CN CN202410039388.XA patent/CN117860958B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019203167A1 (en) * | 2010-11-10 | 2019-05-30 | Prokidney | Injectable formulations for organ augmentation |
CA3063832A1 (en) * | 2017-05-17 | 2018-11-22 | Uvic Industry Partnerships Inc. | Wound covering for wound monitoring and therapeutic agent delivery |
Also Published As
Publication number | Publication date |
---|---|
CN117860958A (en) | 2024-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Farahani et al. | Wound healing: from passive to smart dressings | |
Talikowska et al. | Application of conducting polymers to wound care and skin tissue engineering: A review | |
Mehrabani et al. | Preparation of biocompatible and biodegradable silk fibroin/chitin/silver nanoparticles 3D scaffolds as a bandage for antimicrobial wound dressing | |
Singh et al. | Sterculia crosslinked PVA and PVA-poly (AAm) hydrogel wound dressings for slow drug delivery: mechanical, mucoadhesive, biocompatible and permeability properties | |
Chopra et al. | Strategies and therapies for wound healing: a review | |
Yang et al. | Nanoclay cross-linked semi-IPN silk sericin/poly (NIPAm/LMSH) nanocomposite hydrogel: An outstanding antibacterial wound dressing | |
Xiong et al. | Bio‐functional hydrogel with antibacterial and anti‐inflammatory dual properties to combat with burn wound infection | |
CN110117369B (en) | Antibacterial adhesive conductive hydrogel and preparation method and application thereof | |
CN107929816B (en) | Anti-adhesion material with hemostatic, antibacterial and healing promoting functions and preparation method thereof | |
CN106512064A (en) | Skin wound dressing with antimicrobial property and preparation method of skin wound dressing | |
Gupta et al. | Poly (3, 4‐ethylenedioxythiophene): Poly (styrene sulfonate) in antibacterial, tissue engineering and biosensors applications: Progress, challenges and perspectives | |
CN115124738B (en) | Double-layer bionic drug-loaded hydrogel and preparation and application thereof | |
CN109731130A (en) | A kind of method that low-temperature biological 3D printing technique prepares hydrogel Wound dressing | |
Pajooh et al. | Biomimetic VEGF-loaded bilayer scaffold fabricated by 3D printing and electrospinning techniques for skin regeneration | |
Wang et al. | Sustained release of EGF/bFGF growth factors achieved by mussel-inspired core–shell nanofibers with hemostatic and anti-inflammatory effects for promoting wound healing | |
Huang et al. | A multifunctional 3D dressing unit based on the core–shell hydrogel microfiber for diabetic foot wound healing | |
CN107823699A (en) | Bleeding stopping and adherence preventing film and preparation method thereof | |
Han et al. | Bilayer dressing based on aerogel/electrospun mats with self-catalytic hydrogen sulfide generation and enhanced antioxidant ability | |
CN117860958B (en) | Octopus-based ink-jet type temperature-sensitive antibacterial dressing, and preparation method and application thereof | |
Yi et al. | Highly hygroscopicity and antioxidant nanofibrous dressing base on alginate for accelerating wound healing | |
Rashdan et al. | Traditional and modern wound dressings—characteristics of ideal wound dressings | |
Yuan et al. | Recent advances in harnessing biological macromolecules for wound management: a review | |
Fu et al. | Antibacterial, wet adhesive, and healing-promoting nanosheets for the treatment of oral ulcers | |
Li et al. | “one stone four birds” strategy of advanced hydrogel system based on eight-arm nanocages to promote chronic wound healing in diabetes | |
CN113368037B (en) | Bovine lactoferrin peptide nanoparticle-loaded chitosan temperature-sensitive hydrogel and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |